Abstract

The thyrotropin-releasing hormone (TRH) test, that is, measurement of serum levels of thyroid-stimulating hormone (TSH) following TRH administration, is inexpensive, safe, rapidly conducted, depends upon a radioimmunoassay now generally available, and does not require a high level of patient cooperation. It is noteworthy that in psychiatric patients in whom a diminished or blunted TSH response to TRH has been identified, no endocrine explanation has yet been identified. Factors that are known to reduce the TRH-induced TSH response are: increasing age, male sex, acute starvation, chronic renal failure, Klinefelter’s syndrome, repetitive administration of TRH, and administration of somatostatin, neurotensin, dopamine, thyroid hormones, and glucocorticoids (see Loosen 1986, 1988, for a review). Moreover, several drugs can cause abnormal, i.e., attenuated or exaggerated TRH test results (Wenzel 1981; Table 1). These need to be considered whether one performs the TRH test for psychoendocrine purposes or for diagnosis of endocrine disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.